Get Attitude, Drive Cultural Transformation, Fred Hassan Tells Execs At TAP
This article was originally published in The Pink Sheet Daily
Executive Summary
Cultural transformation was the main topic of Warburg Pincus managing director Fred Hassan’s keynote talk at the Therapeutic Area Partnerships meeting on Nov. 19, where the audience also drew on the investor’s extensive track record leading some of pharma’s most successful turnarounds.
You may also be interested in...
Priority Of Merck's Integration Of Schering Is Retaining Top R&D Talent - Kim
Merck's acquisition of Schering-Plough won't close until the fourth quarter, but the drug maker is already wading through a pipeline review to determine which research programs will get a green light as part of the combined company and which ones might get shelved
What Fred Said: Schering-Plough's Hassan On Life In Big Pharma
Fred Hassan's days as chairman of Schering-Plough are numbered, and he hasn't indicated his next step once his company's merger with Merck closes, likely later this year. He remained cagey - giving only a few indirect clues about his preferences in an interview held Sept. 23 as part of Windhover's Pharmaceutical Strategic Alliances conference in New York City
Schering’s Organon Grab Made Merck's Merger Magic Happen
Takeover in 2007 proved no permanent fix for Schering, but it was enough to lure an even bigger deal.